PPARD and neurodegenerative disease: Although NeuN may not be a confirmative marker for neuronal death [50] and our data do not represent absolute neuronal counts, our data are supported by studies showing the neuroprotective effect of PPARδ agonists in various models of neurodegenerative diseases [13,15-17,51] mainly via reducing inflammation and oxidative stress.